IFNG and psoriasis: Our results suggest IFN-γ/TNF-α synergy may provide a critical pro-inflammatory link between psoriatic skin inflammation and distant vessel atherosclerosis, and identifies that potential blockade of both IFN-γ and TNF-α as a novel therapeutic target in psoriasis-associated atherogenesis.